Clinical trial / 2014
Maternal DHA supplementation during pregnancy did not enhance attention or working memory and inhibitory control in term-born preschoolers.
Mothers were randomly allocated to receive 800 mg DHA/d or placebo from ~20 weeks of gestation until birth, and 158 term-born children completed assessments at a mean of 27 ± 2 months. There was no effect of supplementation on primary outcomes, including distractibility (mean difference: -0.2 s; 95% CI: -0.7, 0.4 s) and WMIC (mean difference: 8.9 mm; 95% CI: -10.6, 28.3 mm). Treatment children looked away from toys fewer times with competing toys but less accurately remembered a repeated hiding location, which was not consistent with other outcomes and may have been due to chance.
- Study type
- Randomized controlled trial
- Who was studied
- 185 term-born children of mothers randomized to DHA or placebo (158 completed assessments at 27 months)
- What was measured
- Child attention (distractibility) and working memory and inhibitory control (WMIC)
THE PAPER
Randomized controlled trial of maternal omega-3 long-chain PUFA supplementation during pregnancy and early childhood development of attention, working memory, and inhibitory control.
Gould JF, Makrides M, Colombo J, Smithers LG. Am J Clin Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.